The United States will facilitate the supply of supplies for the Covid vaccine: Kamala Harris to Prime Minister Modi | India News
The United States also launched a vaccine sharing initiative in which it would share 25 million doses with dozens of countries around the world, including India. The White House told reporters it would lift restrictions on the export of components for the AstraZeneca and Novavax vaccines, which will help SII increase vaccine production substantially.
“I spoke with @VP Kamala Harris recently. I deeply appreciate the guarantee of vaccine supplies to India as part of the US Strategy for Global Vaccine Exchange. I also thanked her for all the support and solidarity from the government From the US, Business and the Indian Diaspora, ”tweeted Prime Minister Modi.
I spoke to @VP Kamala Harris a little while ago. I deeply appreciate the guarantee of vaccine supplies to India as a peer… https://t.co/r3kiqDseTG
– Narendra Modi (@narendramodi) 1622736055000
An official reading of the Modi-Harris conversation said that Harris briefed Modi on “US plans to make Covid-19 vaccines available to other countries, including India, under its’ Strategy for Exchange World Vaccine ‘. The leaders discussed ongoing efforts to strengthen the healthcare supply chain between the US and India, including in the area of vaccine manufacturing. They highlighted the potential of the India-US partnership, as well as the Quad vaccine initiative, to address the long-term health impact of the pandemic. ”
In a briefing, Jake Sullivan, the US NSA, said: “The President promised to ensure that India received the doses and gave them an allocation not only under the regional portion of this through COVAX, but an additional allocation from our discretionary portion … it was something I wanted to do. “He said that the United States would share 80 million doses by the end of June, but that this is just the beginning of the United States sharing vaccines with other countries without any conditions. previous “.
According to a fact sheet published by the US, approximately 7 million doses would be shipped to India and several other Asian countries. So while India will receive only a relatively small number of doses, opening up supply chains for Indian manufacturers is of greater importance.
The White House announcement on Thursday came after US President Joe Biden announced his administration’s decision to distribute the first 25 million of the 80 million AstraZeneca vaccines to a host of different countries around of the world.
The United States has used a Defense Production Act of 1950 to prioritize vaccine supplies for American manufacturers. Today’s decision will remove that restriction. “We are moving the DPA priority classifications for the AstraZeneca, Novavax and Sanofi vaccines. This action will allow US-based companies to supply them to vaccine manufacturers to make their own decisions, ”said the White House Covid response team.
The US decision will allow SII, which makes both the AstraZeneca and Novavax vaccines, to rapidly increase production. India’s demand for vaccines has sharpened after a second surge in a mutant strain of the coronavirus took a heavy toll in the past seven weeks. Rapid vaccination is considered the only way out of the pandemic.
The serum currently produces around 65 million vaccines a month, but with a liberalized supply chain, it will aim to produce more than 100 million a month.
The US decision will help India vaccinate its own population at a faster rate in the coming months, when its own production is still accelerating. Many experts have said that India would have to vaccinate about 8 million a day to wait to get to a place where the majority of Indians are vaccinated, in order to put the virus into retreat.
Equally important is the fact that India, as the world’s largest vaccine manufacturer, will have to re-export vaccines, which would also be one of the key goals of the Biden Administration. Senior US officials had indicated to Foreign Minister S Jaishankar during his recent visit to the United States that they would help with supplies, but that India had to resume its role as a vaccine manufacturer.